SCHEMBL7510755

SCHEMBL7510755

COC=C1CCc2ccc(OC)cc2C1=O

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAOB P27338 2/20 0.67
▸ CYP19A1 P11511 5/20 0.64
▸ ALDH1A1 P00352 4/20 0.61
▸ SMN1; SMN2 Q16637 4/20 0.61
▸ NPC1 O15118 3/20 0.61
▸ RAB9A P51151 3/20 0.61
▸ MAOA P21397 2/20 0.61
▸ LMNA P02545 2/20 0.61
▸ NPSR1 Q6W5P4 1/20 0.61
▸ ACHE P22303 1/20 0.54
▸ MIF P14174 3/20 0.53
▸ METAP1 P53582 1/20 0.51
▸ MAPT P10636 4/20 0.51
▸ CYP26A1 O43174 3/20 0.51
▸ CYP11B2 P19099 2/20 0.51
▸ MEN1 O00255 1/20 0.51
▸ PKM P14618 1/20 0.51
▸ KMT2A Q03164 1/20 0.51
▸ ATM Q13315 1/20 0.51
▸ L3MBTL1 Q9Y468 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7517262 0.89 MIF (0.66) CYP19A1ALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL29127815 0.87 CYP19A1 (0.60) MAOBCYP19A1ALDH1A1SMN1; SMN2NPC1
SCHEMBL6361474 0.85 MAOB (0.67) MAOBCYP19A1ALDH1A1SMN1; SMN2NPC1
SCHEMBL6361472 0.85 MAOB (0.67) MAOBCYP19A1ALDH1A1SMN1; SMN2NPC1
SCHEMBL3502646 0.82 MAOB (0.85) MAOBCYP19A1ALDH1A1SMN1; SMN2NPC1
SCHEMBL6990658 0.82 MAOB (0.64) MAOBCYP19A1ALDH1A1SMN1; SMN2NPC1
SCHEMBL17571252 0.82 MAOB (0.64) MAOBCYP19A1ALDH1A1SMN1; SMN2NPC1
SCHEMBL6990660 0.82 MAOB (0.64) MAOBCYP19A1ALDH1A1SMN1; SMN2NPC1
SCHEMBL13254636 0.82 MAOB (0.85) MAOBCYP19A1ALDH1A1SMN1; SMN2NPC1
SCHEMBL30832103 0.79 MAOB (0.79) MAOBCYP19A1ALDH1A1SMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0856001-B1 PYRIMIDINE DERIVATIVES AS 5HT2C RECEPTOR ANTAGONISTS HOFFMANN LA ROCHE (CH) 2002-08-28 — — EP disclosed
EP-0856001-A1 PYRIMIDINE DERIVATIVES AS 5HT 2C?-RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 1998-08-05 — — EP disclosed
US-5753663-A 5HT2C ANTAGONIST, USEFUL FOR TREATING ANXIETY, PAIN, OBSESSIVE COMPULSIVE DISORDER, ALCOHOLISM, DEPRESSION, MIGRAINE, SLEEP DISORDER, ANOREXIA NERVOSA AND PRIAPISM SYNTEX (U.S.A.) INC. (US) 1998-05-19 — — US disclosed
WO-1997012880-A1 PYRIMIDINE DERIVATIVES AS 5HT2C-RECEPTOR ANTAGONISTS F.HOFFMANN-LA ROCHE AG (CH) 1997-04-10 — — WO disclosed
Send feedback